Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17169884

Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals

Author
HIRSCH, Mark1 ; O'DONNELL, John2 ; OLSSON, Anders3
[1] AstraZeneca, Wilmslow, United Kingdom
[2] AstraZeneca, Wilmington, DE, United States
[3] University Hospital, Linkoping, Sweden
Source

International journal of cardiology. 2005, Vol 104, Num 3, pp 251-256, 6 p ; ref : 40 ref

CODEN
IJCDD5
ISSN
0167-5273
Scientific domain
Cardiology, blood circulation, phlebology
Publisher
Elsevier Science, Shannon
Publication country
Ireland
Document type
Article
Language
English
Author keyword
Atorvastatin Cost-effectiveness LDL-C goals Rosuvastatin
Keyword (fr)
Appareil circulatoire Atorvastatine Cardiologie Cholestérol Coût Economie santé Etude comparative Phlébologie Rosuvastatine Santé publique
Keyword (en)
Circulatory system Atorvastatin Cardiology Cholesterol Costs Health economy Comparative study Phlebology Rosuvastatin Public health
Keyword (es)
Aparato circulatorio Atorvastatina Cardiología Colesterol Coste Economía salud Estudio comparativo Flebología Rosuvastatina Salud pública
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system

Discipline
Cardiology. Circulatory system
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
17169884

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web